시장조사 보고서 : 세계의 원시 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Hypermetropia Treatment Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K00142 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 104 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 원시 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (수술 치료, 렌즈 교정)와 용도별 시장규모 (병원, 전문 센터, 진단 센터, 클리닉, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 원시 치료 시장 점유율
- 지역별 원시 치료 시장규모
- 주요지역의 종류별 시장규모 (수술 치료, 렌즈 교정)
- 주요지역의 용도별 시장규모 (병원, 전문 센터, 진단 센터, 클리닉, 기타)
- 미주의 원시 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 원시 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 원시 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 원시 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 원시 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Allergan plc, Abbott Laboratories Inc., ALCON VISION LLC, Bausch + Lomb Incorporated, Carl Zeiss Inc., Essilor Ltd., Haag-Streit UK, Johnson & Johnson Vision, Lasersight Technologies Inc., Nidek Co. Ltd., ORASIS Pharmaceuticals Ltd., Topcon Corporation, Visioneering Technologies, Inc., Ziemer Ophthalmic Systems AG
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Hypermetropia Treatment will have significant change from previous year. By the most conservative estimates of global Hypermetropia Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hypermetropia Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hypermetropia Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Surgery Treatment
Lens Correction

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Specialty Centers
Diagnostic Centers
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Allergan plc
Abbott Laboratories Inc.
ALCON VISION LLC
Bausch + Lomb Incorporated
Carl Zeiss Inc.
Essilor Ltd.
Haag-Streit UK
Johnson & Johnson Vision
Lasersight Technologies Inc.
Nidek Co. Ltd.
ORASIS Pharmaceuticals Ltd.
Topcon Corporation
Visioneering Technologies, Inc.
Ziemer Ophthalmic Systems AG

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hypermetropia Treatment Market Size 2016-2026
2.1.2 Hypermetropia Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Hypermetropia Treatment Segment by Type
2.2.1 Surgery Treatment
2.2.2 Surgery Treatment
2.3 Hypermetropia Treatment Market Size by Type
2.3.1 Global Hypermetropia Treatment Market Size CAGR by Type
2.3.2 Global Hypermetropia Treatment Market Size Market Share by Type (2016-2021)
2.4 Hypermetropia Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Centers
2.4.3 Diagnostic Centers
2.4.4 Clinics
2.4.5 Others
2.5 Hypermetropia Treatment Market Size by Application
2.5.1 Global Hypermetropia Treatment Market Size CAGR by Application
2.5.2 Global Hypermetropia Treatment Market Size Market Share by Application (2016-2021)

3 Hypermetropia Treatment Market Size by Players
3.1 Hypermetropia Treatment Market Size Market Share by Players
3.1.1 Global Hypermetropia Treatment Revenue by Players (2019-2021E)
3.1.2 Global Hypermetropia Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Hypermetropia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Hypermetropia Treatment by Regions
4.1 Hypermetropia Treatment Market Size by Regions (2016-2021)
4.2 Americas Hypermetropia Treatment Market Size Growth (2016-2021)
4.3 APAC Hypermetropia Treatment Market Size Growth (2016-2021)
4.4 Europe Hypermetropia Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Hypermetropia Treatment Market Size Growth (2016-2021)

5 Americas
5.1 Americas Hypermetropia Treatment Market Size by Country (2016-2021)
5.2 Americas Hypermetropia Treatment Market Size by Type (2016-2021)
5.3 Americas Hypermetropia Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hypermetropia Treatment Market Size by Region (2016-2021)
6.2 APAC Hypermetropia Treatment Market Size by Type (2016-2021)
6.3 APAC Hypermetropia Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hypermetropia Treatment by Country (2016-2021)
7.2 Europe Hypermetropia Treatment Market Size by Type (2016-2021)
7.3 Europe Hypermetropia Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hypermetropia Treatment by Region (2016-2021)
8.2 Middle East & Africa Hypermetropia Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Hypermetropia Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Hypermetropia Treatment Market Forecast
10.1 Global Hypermetropia Treatment Forecast by Regions (2021-2026)
10.1.1 Global Hypermetropia Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Hypermetropia Treatment Forecast
10.1.3 APAC Hypermetropia Treatment Forecast
10.1.4 Europe Hypermetropia Treatment Forecast
10.1.5 Middle East & Africa Hypermetropia Treatment Forecast
10.2 Americas Hypermetropia Treatment Forecast by Countries (2021-2026)
10.2.1 United States Hypermetropia Treatment Market Forecast
10.2.2 Canada Hypermetropia Treatment Market Forecast
10.2.3 Mexico Hypermetropia Treatment Market Forecast
10.2.4 Brazil Hypermetropia Treatment Market Forecast
10.3 APAC Hypermetropia Treatment Forecast by Region (2021-2026)
10.3.1 China Hypermetropia Treatment Market Forecast
10.3.2 Japan Hypermetropia Treatment Market Forecast
10.3.3 Korea Hypermetropia Treatment Market Forecast
10.3.4 Southeast Asia Hypermetropia Treatment Market Forecast
10.3.5 India Hypermetropia Treatment Market Forecast
10.3.6 Australia Hypermetropia Treatment Market Forecast
10.4 Europe Hypermetropia Treatment Forecast by Country (2021-2026)
10.4.1 Germany Hypermetropia Treatment Market Forecast
10.4.2 France Hypermetropia Treatment Market Forecast
10.4.3 UK Hypermetropia Treatment Market Forecast
10.4.4 Italy Hypermetropia Treatment Market Forecast
10.4.5 Russia Hypermetropia Treatment Market Forecast
10.5 Middle East & Africa Hypermetropia Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Hypermetropia Treatment Market Forecast
10.5.2 South Africa Hypermetropia Treatment Market Forecast
10.5.3 Israel Hypermetropia Treatment Market Forecast
10.5.4 Turkey Hypermetropia Treatment Market Forecast
10.5.5 GCC Countries Hypermetropia Treatment Market Forecast
10.6 Global Hypermetropia Treatment Forecast by Type (2021-2026)
10.7 Global Hypermetropia Treatment Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Allergan plc
11.1.1 Allergan plc Company Information
11.1.2 Allergan plc Hypermetropia Treatment Product Offered
11.1.3 Allergan plc Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Allergan plc Main Business Overview
11.1.5 Allergan plc Latest Developments
11.2 Abbott Laboratories Inc.
11.2.1 Abbott Laboratories Inc. Company Information
11.2.2 Abbott Laboratories Inc. Hypermetropia Treatment Product Offered
11.2.3 Abbott Laboratories Inc. Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Abbott Laboratories Inc. Main Business Overview
11.2.5 Abbott Laboratories Inc. Latest Developments
11.3 ALCON VISION LLC
11.3.1 ALCON VISION LLC Company Information
11.3.2 ALCON VISION LLC Hypermetropia Treatment Product Offered
11.3.3 ALCON VISION LLC Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 ALCON VISION LLC Main Business Overview
11.3.5 ALCON VISION LLC Latest Developments
11.4 Bausch + Lomb Incorporated
11.4.1 Bausch + Lomb Incorporated Company Information
11.4.2 Bausch + Lomb Incorporated Hypermetropia Treatment Product Offered
11.4.3 Bausch + Lomb Incorporated Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Bausch + Lomb Incorporated Main Business Overview
11.4.5 Bausch + Lomb Incorporated Latest Developments
11.5 Carl Zeiss Inc.
11.5.1 Carl Zeiss Inc. Company Information
11.5.2 Carl Zeiss Inc. Hypermetropia Treatment Product Offered
11.5.3 Carl Zeiss Inc. Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Carl Zeiss Inc. Main Business Overview
11.5.5 Carl Zeiss Inc. Latest Developments
11.6 Essilor Ltd.
11.6.1 Essilor Ltd. Company Information
11.6.2 Essilor Ltd. Hypermetropia Treatment Product Offered
11.6.3 Essilor Ltd. Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Essilor Ltd. Main Business Overview
11.6.5 Essilor Ltd. Latest Developments
11.7 Haag-Streit UK
11.7.1 Haag-Streit UK Company Information
11.7.2 Haag-Streit UK Hypermetropia Treatment Product Offered
11.7.3 Haag-Streit UK Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Haag-Streit UK Main Business Overview
11.7.5 Haag-Streit UK Latest Developments
11.8 Johnson & Johnson Vision
11.8.1 Johnson & Johnson Vision Company Information
11.8.2 Johnson & Johnson Vision Hypermetropia Treatment Product Offered
11.8.3 Johnson & Johnson Vision Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Johnson & Johnson Vision Main Business Overview
11.8.5 Johnson & Johnson Vision Latest Developments
11.9 Lasersight Technologies Inc.
11.9.1 Lasersight Technologies Inc. Company Information
11.9.2 Lasersight Technologies Inc. Hypermetropia Treatment Product Offered
11.9.3 Lasersight Technologies Inc. Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Lasersight Technologies Inc. Main Business Overview
11.9.5 Lasersight Technologies Inc. Latest Developments
11.10 Nidek Co. Ltd.
11.10.1 Nidek Co. Ltd. Company Information
11.10.2 Nidek Co. Ltd. Hypermetropia Treatment Product Offered
11.10.3 Nidek Co. Ltd. Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Nidek Co. Ltd. Main Business Overview
11.10.5 Nidek Co. Ltd. Latest Developments
11. ORASIS Pharmaceuticals Ltd.
11.11.1 ORASIS Pharmaceuticals Ltd. Company Information
11.11.2 ORASIS Pharmaceuticals Ltd. Hypermetropia Treatment Product Offered
11.11.3 ORASIS Pharmaceuticals Ltd. Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 ORASIS Pharmaceuticals Ltd. Main Business Overview
11.11.5 ORASIS Pharmaceuticals Ltd. Latest Developments
11.12 Topcon Corporation
11.12.1 Topcon Corporation Company Information
11.12.2 Topcon Corporation Hypermetropia Treatment Product Offered
11.12.3 Topcon Corporation Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Topcon Corporation Main Business Overview
11.12.5 Topcon Corporation Latest Developments
11.13 Visioneering Technologies, Inc.
11.13.1 Visioneering Technologies, Inc. Company Information
11.13.2 Visioneering Technologies, Inc. Hypermetropia Treatment Product Offered
11.13.3 Visioneering Technologies, Inc. Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Visioneering Technologies, Inc. Main Business Overview
11.13.5 Visioneering Technologies, Inc. Latest Developments
11.14 Ziemer Ophthalmic Systems AG
11.14.1 Ziemer Ophthalmic Systems AG Company Information
11.14.2 Ziemer Ophthalmic Systems AG Hypermetropia Treatment Product Offered
11.14.3 Ziemer Ophthalmic Systems AG Hypermetropia Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Ziemer Ophthalmic Systems AG Main Business Overview
11.14.5 Ziemer Ophthalmic Systems AG Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Hypermetropia Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Surgery Treatment
Table 3. Major Players of Lens Correction
Table 4. Hypermetropia Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Hypermetropia Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Hypermetropia Treatment Market Size Market Share by Type (2016-2021)
Table 7. Hypermetropia Treatment Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Hypermetropia Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Hypermetropia Treatment Market Size Market Share by Application (2016-2021)
Table 10. Global Hypermetropia Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Hypermetropia Treatment Revenue Market Share by Players (2019-2021E)
Table 12. Hypermetropia Treatment Key Players Head office and Products Offered
Table 13. Hypermetropia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Hypermetropia Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Hypermetropia Treatment Market Size Market Share by Regions 2016-2021
Table 18. Americas Hypermetropia Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Hypermetropia Treatment Market Size Market Share by Country (2016-2021)
Table 20. Americas Hypermetropia Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Hypermetropia Treatment Market Size Market Share by Type (2016-2021)
Table 22. Americas Hypermetropia Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Hypermetropia Treatment Market Size Market Share by Application (2016-2021)
Table 24. APAC Hypermetropia Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Hypermetropia Treatment Market Size Market Share by Region (2016-2021)
Table 26. APAC Hypermetropia Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Hypermetropia Treatment Market Size Market Share by Type (2016-2021)
Table 28. APAC Hypermetropia Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Hypermetropia Treatment Market Size Market Share by Application (2016-2021)
Table 30. Europe Hypermetropia Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Hypermetropia Treatment Market Size Market Share by Country (2016-2021)
Table 32. Europe Hypermetropia Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Hypermetropia Treatment Market Size Market Share by Type (2016-2021)
Table 34. Europe Hypermetropia Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Hypermetropia Treatment Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Hypermetropia Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Hypermetropia Treatment Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Hypermetropia Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Hypermetropia Treatment Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Hypermetropia Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Hypermetropia Treatment Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Hypermetropia Treatment
Table 43. Key Application and Potential Industries of Hypermetropia Treatment
Table 44. Key Challenges of Hypermetropia Treatment
Table 45. Key Trends of Hypermetropia Treatment
Table 46. Global Hypermetropia Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Hypermetropia Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Hypermetropia Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Hypermetropia Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Hypermetropia Treatment Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Hypermetropia Treatment Market Size Market Share Forecast by Application (2021-2026)
Table 52. Allergan plc Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 53. Allergan plc Hypermetropia Treatment Product Offered
Table 54. Allergan plc Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Allergan plc Main Business
Table 56. Allergan plc Latest Developments
Table 57. Abbott Laboratories Inc. Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 58. Abbott Laboratories Inc. Hypermetropia Treatment Product Offered
Table 59. Abbott Laboratories Inc. Main Business
Table 60. Abbott Laboratories Inc. Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Abbott Laboratories Inc. Latest Developments
Table 62. ALCON VISION LLC Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 63. ALCON VISION LLC Hypermetropia Treatment Product Offered
Table 64. ALCON VISION LLC Main Business
Table 65. ALCON VISION LLC Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. ALCON VISION LLC Latest Developments
Table 67. Bausch + Lomb Incorporated Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 68. Bausch + Lomb Incorporated Hypermetropia Treatment Product Offered
Table 69. Bausch + Lomb Incorporated Main Business
Table 70. Bausch + Lomb Incorporated Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Bausch + Lomb Incorporated Latest Developments
Table 72. Carl Zeiss Inc. Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 73. Carl Zeiss Inc. Hypermetropia Treatment Product Offered
Table 74. Carl Zeiss Inc. Main Business
Table 75. Carl Zeiss Inc. Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Carl Zeiss Inc. Latest Developments
Table 77. Essilor Ltd. Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 78. Essilor Ltd. Hypermetropia Treatment Product Offered
Table 79. Essilor Ltd. Main Business
Table 80. Essilor Ltd. Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Essilor Ltd. Latest Developments
Table 82. Haag-Streit UK Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 83. Haag-Streit UK Hypermetropia Treatment Product Offered
Table 84. Haag-Streit UK Main Business
Table 85. Haag-Streit UK Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Haag-Streit UK Latest Developments
Table 87. Johnson & Johnson Vision Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 88. Johnson & Johnson Vision Hypermetropia Treatment Product Offered
Table 89. Johnson & Johnson Vision Main Business
Table 90. Johnson & Johnson Vision Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Johnson & Johnson Vision Latest Developments
Table 92. Lasersight Technologies Inc. Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 93. Lasersight Technologies Inc. Hypermetropia Treatment Product Offered
Table 94. Lasersight Technologies Inc. Main Business
Table 95. Lasersight Technologies Inc. Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Lasersight Technologies Inc. Latest Developments
Table 97. Nidek Co. Ltd. Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 98. Nidek Co. Ltd. Hypermetropia Treatment Product Offered
Table 99. Nidek Co. Ltd. Main Business
Table 100. Nidek Co. Ltd. Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Nidek Co. Ltd. Latest Developments
Table 102. ORASIS Pharmaceuticals Ltd. Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 103. ORASIS Pharmaceuticals Ltd. Hypermetropia Treatment Product Offered
Table 104. ORASIS Pharmaceuticals Ltd. Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. ORASIS Pharmaceuticals Ltd. Main Business
Table 106. ORASIS Pharmaceuticals Ltd. Latest Developments
Table 107. Topcon Corporation Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 108. Topcon Corporation Hypermetropia Treatment Product Offered
Table 109. Topcon Corporation Main Business
Table 110. Topcon Corporation Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. Topcon Corporation Latest Developments
Table 112. Visioneering Technologies, Inc. Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 113. Visioneering Technologies, Inc. Hypermetropia Treatment Product Offered
Table 114. Visioneering Technologies, Inc. Main Business
Table 115. Visioneering Technologies, Inc. Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. Visioneering Technologies, Inc. Latest Developments
Table 117. Ziemer Ophthalmic Systems AG Details, Company Type, Hypermetropia Treatment Area Served and Its Competitors
Table 118. Ziemer Ophthalmic Systems AG Hypermetropia Treatment Product Offered
Table 119. Ziemer Ophthalmic Systems AG Main Business
Table 120. Ziemer Ophthalmic Systems AG Hypermetropia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Ziemer Ophthalmic Systems AG Latest Developments
List of Figures
Figure 1. Hypermetropia Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hypermetropia Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Hypermetropia Treatment Market Size Market Share by Type in 2020
Figure 7. Hypermetropia Treatment in Hospitals
Figure 8. Global Hypermetropia Treatment Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Hypermetropia Treatment in Specialty Centers
Figure 10. Global Hypermetropia Treatment Market: Specialty Centers (2016-2021) & ($ Millions)
Figure 11. Hypermetropia Treatment in Diagnostic Centers
Figure 12. Global Hypermetropia Treatment Market: Diagnostic Centers (2016-2021) & ($ Millions)
Figure 13. Hypermetropia Treatment in Clinics
Figure 14. Global Hypermetropia Treatment Market: Clinics (2016-2021) & ($ Millions)
Figure 15. Hypermetropia Treatment in Others
Figure 16. Global Hypermetropia Treatment Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Hypermetropia Treatment Market Size Market Share by Application in 2020
Figure 18. Global Hypermetropia Treatment Revenue Market Share by Player in 2020
Figure 19. Global Hypermetropia Treatment Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Hypermetropia Treatment Market Size 2016-2021 ($ Millions)
Figure 21. APAC Hypermetropia Treatment Market Size 2016-2021 ($ Millions)
Figure 22. Europe Hypermetropia Treatment Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Hypermetropia Treatment Market Size 2016-2021 ($ Millions)
Figure 24. Americas Hypermetropia Treatment Market Size Market Share by Country in 2020
Figure 25. Americas Hypermetropia Treatment Market Size Market Share by Type in 2020
Figure 26. Americas Hypermetropia Treatment Market Size Market Share by Application in 2020
Figure 27. United States Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Hypermetropia Treatment Market Size Market Share by Regions in 2020
Figure 31. APAC Hypermetropia Treatment Market Size Market Share by Type in 2020
Figure 32. APAC Hypermetropia Treatment Market Size Market Share by Application in 2020
Figure 33. China Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Hypermetropia Treatment Market Size Market Share by Country in 2020
Figure 40. Europe Hypermetropia Treatment Market Size Market Share by Type in 2020
Figure 41. Europe Hypermetropia Treatment Market Size Market Share by Application in 2020
Figure 42. Germany Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Hypermetropia Treatment Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Hypermetropia Treatment Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Hypermetropia Treatment Market Size Market Share by Application in 2020
Figure 50. Egypt Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Hypermetropia Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 56. APAC Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 57. Europe Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 59. United States Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 60. Canada Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 63. China Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 64. Japan Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 65. Korea Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 67. India Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Australia Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 69. Germany Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 70. France Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 71. UK Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 72. Italy Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 73. Russia Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 74. Spain Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 77. Israel Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Hypermetropia Treatment Market Size 2021-2026 ($ Millions)
Figure 79. GCC Country Hypermetropia Treatment Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 원시 치료 시장예측 2021년-2026년] (코드 : LPI-2201K00142) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 원시 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 노안 치료 장치 시장예측 2021년-2026년
LPI-2201K02526 / LP Information / 2021년 12월 / 본 조사보고서는 노안 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Presbyopia Treatment Device will have significant change from previous year. By the most conservative estimates of global Presbyopia Treatment Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 고콜레스테롤혈증 치료 시장예측 2021년-2026년
LPI-2201K00141 / LP Information / 2021년 12월 / 본 조사보고서는 고콜레스테롤혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hypercholesterolemia Treatment will have significant change from previous year. By the most conservative estimates of global Hypercholesterolemia Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 과민성 방광 치료 시장예측 2021년-2026년
LPI-2201K02444 / LP Information / 2021년 12월 / 본 조사보고서는 과민성 방광 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Overactive Bladder Treatment will have significant change from previous year. By the most conservative estimates of global Overactive Bladder Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4901 million in...

세계의 신경 장애성 통증 치료 시장예측 2021년-2026년
LPI-2201K02241 / LP Information / 2021년 12월 / 본 조사보고서는 신경 장애성 통증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Neuropathy Pain Treatment will have significant change from previous year. By the most conservative estimates of global Neuropathy Pain Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 8078.4 million in...

세계의 시차 적응 치료 시장예측 2021년-2026년
LPI-2201K00080 / LP Information / 2021년 12월 / 본 조사보고서는 시차 적응 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Jet Lag Treatment will have significant change from previous year. By the most conservative estimates of global Jet Lag Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 420.5 million in...

세계의 녹내장 치료 시장예측 2021년-2026년
LPI-2201K00104 / LP Information / 2021년 12월 / 본 조사보고서는 녹내장 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Glaucoma Treatment will have significant change from previous year. By the most conservative estimates of global Glaucoma Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 저나트륨 혈증 치료 시장예측 2021년-2026년
LPI-2201K00145 / LP Information / 2021년 12월 / 본 조사보고서는 저나트륨 혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hyponatremia Treatment will have significant change from previous year. By the most conservative estimates of global Hyponatremia Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...